These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6340858)
41. [Enzymuria and kidney diseases in childhood]. Ehrich JH; Wurster U; Lütge M; Doehring E; Oemar B Monatsschr Kinderheilkd; 1986 Dec; 134(12):832-9. PubMed ID: 2881198 [TBL] [Abstract][Full Text] [Related]
42. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases]. Zandvliet EE; Giesberts MA; van Gelderen HH Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088 [TBL] [Abstract][Full Text] [Related]
43. [N-acetyl-beta-D-glucosaminidase (NAG) in the urine. An additional parameter for diagnosing the site of urinary tract infection]. Ring E; Erwa W; Zobel G Monatsschr Kinderheilkd; 1989 May; 137(5):280-3. PubMed ID: 2739666 [TBL] [Abstract][Full Text] [Related]
44. The effects of age and urine concentration on lysozyme and N-acetyl-beta-D-glucosaminidase (NAG) content in urine. Houser MT Ann Clin Biochem; 1986 May; 23 ( Pt 3)():297-302. PubMed ID: 3789636 [TBL] [Abstract][Full Text] [Related]
45. Colorimetric assay for N-acetyl-beta-D-glucosaminidase (NAG) in pathological urine using the omega-nitrostyryl substrate: the development of a kit and the comparison of manual procedure with the automated fluorimetric method. Yuen CT; Kind PR; Price RG; Praill PF; Richardson AC Ann Clin Biochem; 1984 Jul; 21 ( Pt 4)():295-300. PubMed ID: 6548349 [TBL] [Abstract][Full Text] [Related]
46. Urinary fibrin degradation products--a three year comparative study. Schmitt E; Seyfarth M; Templin R; Schneider P; Klinkmann H Proc Eur Dial Transplant Assoc; 1978; 15():466-72. PubMed ID: 368788 [TBL] [Abstract][Full Text] [Related]
47. Urinary N-acetyl-beta-D-glucosaminidase in the patients with hyperthyroidism. Tominaga M; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Honda M; Mokuda O; Ikeda T; Mashiba H Horm Metab Res; 1989 Aug; 21(8):438-40. PubMed ID: 2793065 [TBL] [Abstract][Full Text] [Related]
49. [Urinary N-acetyl-beta-glucosaminidase as index of renal toxicity (author's transl)]. Oudart N; Marcher K; Lacour B; Boulu RG; Guichard C Toxicol Eur Res; 1981 May; 3(3):149-51. PubMed ID: 7281165 [TBL] [Abstract][Full Text] [Related]
50. Enzymuria as a marker of renal injury and disease: studies of N-acetyl-beta-glucosaminidase in the general population and in patients with renal disease. Kunin CM; Chesney RW; Craig WA; England AC; DeAngelis C Pediatrics; 1978 Nov; 62(5):751-60. PubMed ID: 364392 [TBL] [Abstract][Full Text] [Related]
51. [Changes in N-acetyl-beta-glucosaminidase (NAG) in prostatitis patients]. Yasumoto R; Kobayakawa H; Kakinoki K; Iseki T; Umeda M; Kawashima H; Moriya K; Maekawa M Hinyokika Kiyo; 1986 Jun; 32(6):841-5. PubMed ID: 3766344 [TBL] [Abstract][Full Text] [Related]
52. Minimum steriod requirements in renal transplant patients monitored by urinary fibrin degradation products and complement. Anderton JL; Fananapazir L; Eccleston M Proc Eur Dial Transplant Assoc; 1977; 14():342-50. PubMed ID: 341136 [TBL] [Abstract][Full Text] [Related]
53. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model]. Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687 [TBL] [Abstract][Full Text] [Related]
54. Renal disease in rheumatoid arthritis. Dieppe PA; Doyle DV; Burry HC; Tucker SM Br Med J; 1976 Mar; 1(6010):611-2. PubMed ID: 1252848 [TBL] [Abstract][Full Text] [Related]
55. Urinary N-acetyl-beta-glucosaminidase and the selection of children for radiologic evaluation after urinary tract infection. Johnson CE; Vacca CV; Fattlar D; Fulton DJ; Hall PW Pediatrics; 1990 Aug; 86(2):211-6. PubMed ID: 2371096 [TBL] [Abstract][Full Text] [Related]
56. Kinetic rate assay of urinary N-acetyl-beta-D-glucosaminidase with 2-chloro-4-nitrophenyl-N-acetyl-beta-D-glucosaminide as substrate. Makise J; Saito E; Obuchi M; Kanayama M; Ichikawa K; Harakawa K; Yoshida K Clin Chem; 1988 Oct; 34(10):2140-3. PubMed ID: 3255304 [TBL] [Abstract][Full Text] [Related]
57. [Determination of urinary N-acetyl-beta-D-glucosaminidase (NAG) excretion as a parameter of nephrotoxicity due to cis-platin and the effect of fosfomycin (FOM) on its nephrotoxicity]. Matsuoka R; Inoue T; Miyamura K; Mizutani K; Koike S; Mori H; Kigawa T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Nov; 38(11):2037-44. PubMed ID: 3794453 [TBL] [Abstract][Full Text] [Related]
58. Occupational exposure to chlorinated organic solvents and its effect on the renal excretion of N-acetyl-beta-D-glucosaminidase. Brogren CH; Christensen JM; Rasmussen K Arch Toxicol Suppl; 1986; 9():460-4. PubMed ID: 3468929 [TBL] [Abstract][Full Text] [Related]
59. Two automated procedures for N-acetyl-beta-D-glucosaminidase determination evaluated for detection of drug-induced tubular nephrotoxicity. Goren MP; Wright RK; Osborne S Clin Chem; 1986 Nov; 32(11):2052-5. PubMed ID: 3779949 [TBL] [Abstract][Full Text] [Related]
60. [The significance of determining N-acetylbeta-D-glucosaminidase in the diagnosis of kidney transplant rejection]. Borosová E; Dzúriková V; Reznícek J; Pribylincová V; Zvara V Vnitr Lek; 1980 Jul; 26(7):697-703. PubMed ID: 6998108 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]